Dr. Peter Ferenci

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Approximately 50% of patients with chronic hepatitis C respond to treatment with interferon-α. The aim of this randomized controlled trial was to evaluate whether an increase in dose of interferon-α augments response rate. One hundred thirty-eight patients with newly diagnosed chronic hepatitis C received a three-month course of 3 MU IFN-α2b administered(More)
  • 1